Local Institution - 0236

São Paulo 01509-010

0 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma, Liver Cancer

Studies at this site

• A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation — Running, not enrolling